All Curated Mutation Sites in HPV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HPV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
E1
  
E1^E4
  
E2
  
E5
  
E6
  
E7
  
L1
  
L2
  

Keyword: Cervical Intraepithelial Neoplasia-22659102
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 22659102 A7714G
LCR
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
C
L
View
2 22659102 C7266T
LCR
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
C
L
View
3 22659102 A6014C
L1
L1
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
C
L
View
4 22659102 G41R
E7
E7
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
C
L
View
5 22659102 G63D
E7
E7
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
C
L
View
6 22659102 G694A
E7
E7
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
C
L
View
7 22659102 G761A
E7
E7
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
C
L
View
8 22659102 T744G
E7
E7
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
C
L
View
9 22659102 T803C
E7
E7
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
C
L
View
10 22659102 V77A
E7
E7
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
C
L
View
11 22659102 A140G
E6
E6
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
C
L
View
12 22659102 A184C
E6
E6
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
C
L
View
13 22659102 A313G
E6
E6
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
C
L
View
14 22659102 C307T
E6
E6
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
C
L
View
15 22659102 E25D
E6
E6
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
C
L
View
16 22659102 G266C
E6
E6
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
C
L
View
17 22659102 T11A
E6
E6
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
C
L
View
18 22659102 V53L
E6
E6
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
C
L
View
Contents
Description

The table shows all curated mutation sites of HPV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.